Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group

• Status: Terminated
• Trial end date: 2014-04-01

Summary

The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial.

• Phase: Phase 4

Details

• Lead Sponsor: Mylan Bertek Pharmaceuticals
• Collaborator: Mylan Pharmaceuticals
• Treatments: Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacitracin; Cefazolin; Clotrimazole; Fluconazole; Mafenide; Miconazole; Nystatin; Pharmaceutical Solutions; Piperacillin; Silver Sulfadiazine; Sulfadiazine; Tazobactam; Vancomycin